These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 6678555

  • 1. Treatment of portal hypertension with nadolol in patients with liver cirrhosis.
    Cervera J, Torres-Zamora M, Gutiérrez-Carreño R, Fierro M, Schaeffer L, Landa L.
    Arch Invest Med (Mex); 1983; 14(4):331-41. PubMed ID: 6678555
    [No Abstract] [Full Text] [Related]

  • 2. Carvedilol for portal hypertension in patients with cirrhosis.
    Bosch J.
    Hepatology; 2010 Jun; 51(6):2214-8. PubMed ID: 20513005
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
    Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Cavasin L, Gatta A.
    Aliment Pharmacol Ther; 2005 Sep 01; 22(5):433-9. PubMed ID: 16128681
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis].
    Fedulenkova LV, Drozdov VN, Mikheeva OM, Petrakov AV.
    Eksp Klin Gastroenterol; 2008 Sep 01; (5):37-41. PubMed ID: 19145915
    [No Abstract] [Full Text] [Related]

  • 8. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
    Bondarenko IP, Dubinskiĭ AA, Tereshkin IG.
    Vrach Delo; 1989 Nov 01; (11):19-22. PubMed ID: 2609578
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of essential arterial hypertension with nadolol and bendroflumethiazide].
    Marchetta F, Chiarini C, Degli Esposti E, Santoro A, Sturani A, Zuccalà A, Zucchelli P.
    Clin Ter; 1983 Aug 15; 106(3):209-12. PubMed ID: 6627892
    [No Abstract] [Full Text] [Related]

  • 14. [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo].
    Cherchi A, Sau F, Mercuro G, Seguro C, Lai O.
    Clin Ter; 1985 May 31; 113(4):301-6. PubMed ID: 3893868
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [New trends in the treatment of hemodynamic disorders in liver cirrhosis].
    Vorob'ev LP, Maev IV.
    Klin Med (Mosk); 1991 Sep 31; 69(9):11-4. PubMed ID: 1687073
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG, Albillos A, Bañares R, Turnes J, González R, García-Pagán JC, Bosch J.
    Gastroenterology; 2009 May 31; 136(5):1651-8. PubMed ID: 19208350
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.